Skip to content

Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients

New Strategies for Pulmonary Assessment in Spinal and Chest Wall Deformity

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04977830
Enrollment
0
Registered
2021-07-27
Start date
2026-01-01
Completion date
2026-08-30
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Insufficiency Syndrome

Keywords

Hyperpolarized MRI, Dynamic Lung MRI

Brief summary

Thoracic insufficiency syndrome (TIS) is a complex condition that involves chest wall deformities that can affect normal breathing and lung growth. In most cases, children with TIS are also born with spine disorders such as scoliosis. The inability of the thorax to support normal respiration or lung growth can cause respiratory distress and even mortality. Investigators aim to validate MRI imaging sequences to use as an assessment tool for pulmonary function.

Interventions

DEVICEXenon-129

Patients will undergo a hyperpolarized MRI with administered Xenon gas

Sponsors

Patrick Cahill, MD
Lead SponsorOTHER
Xemed LLC
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Males or females 6 to 18 years old diagnosed with thoracic insufficiency syndrome who are undergoing surgery

Exclusion criteria

* patients not diagnosed with thoracic insufficiency syndrome

Design outcomes

Primary

MeasureTime frameDescription
Analyze volume of lungs at end-inspiration and end-expirationup to 2 yearsInvestigators will analyze lung volume at end-inspiration and end-expiration will be assessed by performing a thoracic dynamic magnetic resonance imaging scan; measured in total volume units (mL)
Xenon-129 MRI Ventilation Mapsup to 2 yearsXenon-129 MRI will be completed to reveal unventilated regions of the lungs where the gas cannot reach after being inhaled due to restrictions of the airways.

Secondary

MeasureTime frameDescription
oxygen partial pressure (PAO2) mapsup to 2 yearsOxygen partial pressure (PAO2) maps will be extracted from 129Xe MRI maps in a single breath-hold. Regions of the lungs that show abnormal PAO2 values are susceptible of improper ventilation or gas exchange.
Forced vital capacity (FVC)up to 2 yearsForced vital capacity will be extracted from the computer-automated dynamic lung MRI software.
Forced expiratory volume (FEV1)up to 2 yearsForced expiratory volume data will be extracted from the computer-automated dynamic lung MRI software to assess the volume of air forced from the lungs
Xenon-129 MRI apparent diffusion coefficient (ADC) mapsup to 2 yearsApparent diffusion coefficient (ADC) maps are extracted from the Xenon-129 MRI from a single breath-hold pulse sequence.
total lung capacityup to 2 yearsTotal lung capacity will be extracted from the computer-automated dynamic lung MRI software.
functional residual capacity (FRC)up to 2 yearsfunctional residual capacity data will be extracted from the computer-automated dynamic lung MRI software to measure the volume in the lungs at the end of passive expiration

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPatrick Cahill, MD

Children's Hopsital of Philadelphia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026